Cerebral paragonimiasis.
D000293:Adolescent; D000328:Adult; D000871:Anthelmintics / Q000627:therapeutic use; D001927:Brain Diseases / Q000145:classification / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D002395:Catecholamines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007723:Korea; D008297:Male; D008875:Middle Aged; D010237:Paragonimiasis / Q000145:classification / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000601:surgery; D011859:Radiography; D013440:Sulfides / Q000627:therapeutic use
D000871:Anthelmintics; D002395:Catecholamines; D013440:Sulfides